Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer
Clinical trial NCT05985330 · RECRUITING
Trial details
- NCT number
- NCT05985330
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-26
- Primary completion
- 2030-09-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.